Nemolizumab Biosimilar – Anti-IL31RA mAb – Research Grade

Reference:
Size

,

Isotype

IgG2, kappa

Brand

Product type

Clonality

Expression system

Applications

,

Product nameNemolizumab Biosimilar - Anti-IL31RA mAb - Research Grade
SourceCAS 1476039-58-3
SpeciesHumanized
Expression systemMammalian cells
Purity>85%
BufferPBS buffer PH7.5
Delivery conditionBlue ice (+4°C)
Delivery Time3-5 days if in stock; 3-5 weeks if production needed
Storage conditionstore at -80°C
BrandProteoGenix
Aliases /SynonymsNemolizumab,CIM 331,IL31RA,anti-IL31RA
ReferencePX-TA1376
NoteFor research use only. Not suitable for clinical or therapeutic use.
IsotypeIgG2-kappa
ClonalityMonoclonal Antibody

Description of Nemolizumab Biosimilar - Anti-IL31RA mAb - Research Grade

General information on Anti-IL31RA[Homo sapiens] (Nemolizumab) Monoclonal Antibody

Nemolizumab is investigated for the treatment of Atopic Dermatitis (AD).

SDS-PAGE for Nemolizumab Biosimilar - Anti-IL31RA mAb

Nemolizumab Biosimilar - Anti-IL31RA mAb, on SDS-PAGE under reducing and non-reducing condition. The gel was stained overnight with Coomassie Blue. The purity of the antibody is greater than 95%.

Reviews

There are no reviews yet.

REVIEW YOUR PRODUCT

Be the first to review “Nemolizumab Biosimilar – Anti-IL31RA mAb – Research Grade”

Your email address will not be published. Required fields are marked *

Related products

Interleukin-31 receptor subunit alpha(IL31RA)
Antigen

Interleukin-31 receptor subunit alpha(IL31RA)

PX-P4802 142€

Contact us

Got a question or need a quote?
Message us and we’ll get back to you 48 hours or less.






    Cart (0 Items)

    Your cart is currently empty.

    View Products